Clinical presentation, diagnosis, pathogenesis and treatment options for lymphocytic colitis (Review)
- Authors:
- Magdy El-Salhy
- Doris Gundersen
- Jan Gunnar Hatlebakk
- Trygve Hausken
-
Affiliations: Section for Gastroenterology, Department of Medicine, Stord Helse-Fonna Hospital, Stord, Norway, Department of Research, Helse-Fonna, Haugesund, Norway, Section for Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway - Published online on: May 21, 2013 https://doi.org/10.3892/ijmm.2013.1385
- Pages: 263-270
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG and Fordtran JS: Chronic diarrhea of unknown origin. Gastroenterology. 78:264–271. 1980.PubMed/NCBI | |
|
Chande N, MacDonald JK and McDonald JW: Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 104:235–241; quiz 234, 242, 2009. | |
|
Pardi DS: Microscopic colitis: an update. Inflamm Bowel Dis. 10:860–870. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pardi DS and Kelly CP: Microscopic colitis. Gastroenterology. 140:1155–1165. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Yen EF and Pardi DS: Review of the microscopic colitides. Curr Gastroenterol Rep. 13:458–464. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Olesen M, Eriksson S, Bohr J, Jarnerot G and Tysk C: Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 53:346–350. 2004.PubMed/NCBI | |
|
Guagnozzi D, Lucendo AJ, Angueira-Lapena T, Gonzalez-Castillo S and Tenias Burillo JM: Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis. 44:384–388. 2012. View Article : Google Scholar | |
|
Fernandez-Banares F, Salas A, Forne M, Esteve M, Espinos J and Viver JM: Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 94:418–423. 1999.PubMed/NCBI | |
|
Fernandez-Banares F, Salas A, Esteve M, et al: Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis. 17:1015–1020. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bjornbak C, Engel PJ, Nielsen PL and Munck LK: Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther. 34:1225–1234. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al: Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 47:1122–1128. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pardi DS, Loftus EV Jr, Smyrk TC, et al: The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 56:504–508. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Williams JJ, Kaplan GG, Makhija S, et al: Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 6:35–40. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rasmussen MA and Munck LK: Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis? Aliment Pharmacol Ther. 36:79–90. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandez-Banares F, Esteve M and Viver JM: Epidemiology of microscopic colitis. Gut. 56:10332007. View Article : Google Scholar : PubMed/NCBI | |
|
Brown WR and Tayal S: Microscopic colitis. A review. J Dig Dis. 14:277–281. 2013. View Article : Google Scholar | |
|
Yen EF and Pardi DS: Review article: microscopic colitis - lymphocytic, collagenous and ‘mast cell’ colitis. Aliment Pharmacol Ther. 34:21–32. 2011. | |
|
Mohamed N, Marais M and Bezuidenhout J: Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol. 17:1996–2002. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pascua MF, Kedia P, Weiner MG, Holmes J, Ellenberg J and Lewis JD: Microscopic colitis and medication use. Clin Med Insights Gastroenterol. 2010:11–19. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Munch A, Aust D, Bohr J, et al: Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 6:932–945. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mahajan D, Goldblum JR, Xiao SY, Shen B and Liu X: Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities. Adv Anat Pathol. 19:28–38. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pardi DS, Ramnath VR, Loftus EV Jr, Tremaine WJ and Sandborn WJ: Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 97:2829–2833. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mullhaupt B, Guller U, Anabitarte M, Guller R and Fried M: Lymphocytic colitis: clinical presentation and long term course. Gut. 43:629–633. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Barta Z, Mekkel G, Csipo I, et al: Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J Gastroenterol. 11:1351–1355. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Olesen M, Eriksson S, Bohr J, Jarnerot G and Tysk C: Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 53:536–541. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Koskela RM, Niemela SE, Karttunen TJ and Lehtola JK: Clinical characteristics of collagenous and lymphocytic colitis. Scand J Gastroenterol. 39:837–845. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Baert F, Wouters K, D'Haens G, et al: Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut. 45:375–381. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Sveinsson OA, Orvar KB, Birgisson S, Agnarsdottir M and Jonasson JG: Clinical features of microscopic colitis in a nation-wide follow-up study in Iceland. Scand J Gastroenterol. 43:955–960. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kao KT, Pedraza BA, McClune AC, et al: Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 15:3122–3127. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liszka L, Woszczyk D and Pajak J: Histopathological diagnosis of microscopic colitis. J Gastroenterol Hepatol. 21:792–797. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Veress B, Lofberg R and Bergman L: Microscopic colitis syndrome. Gut. 36:880–886. 1995. View Article : Google Scholar | |
|
Thijs WJ, van Baarlen J, Kleibeuker JH and Kolkman JJ: Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med. 63:137–140. 2005.PubMed/NCBI | |
|
Fine KD, Seidel RH and Do K: The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc. 51:318–326. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Matteoni CA, Wang N, Goldblum JR, Brzezinski A, Achkar E and Soffer EE: Flexible sigmoidoscopy for the detection of microscopic colitis. Am J Med. 108:416–418. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Taupenot L, Harper KL and O'Connor DT: The chromogranin-secretogranin family. N Engl J Med. 348:1134–1149. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wiedenmann B and Huttner WB: Synaptophysin and chromogranins/secretogranins - widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol. 58:95–121. 1989. View Article : Google Scholar | |
|
Deftos LJ: Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev. 12:181–187. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
El-Salhy M, Lomholt-Beck B and Gundersen D: High chromogranin A cell density in the colon of patients with lymphocytic colitis. Mol Med Rep. 4:603–605. 2011.PubMed/NCBI | |
|
El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Chromogranin A cell density as a diagnostic marker for lymphocytic colitis. Dig Dis Sci. 57:3154–3159. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Irritable Bowel Syndrome: Diagnosis Pathogenesis and Treatment Options. Nova Science Publisher; New York: 2012 | |
|
El-Salhy M, Halwe J, Lomholt-Beck B and Gundersen D: The prevalence of inflammatory bowel diseases and microscopic colitis and colorectal cancer in patients with irritable bowel syndrome. Gastroenterology Insights. 3:7–10. 2011. View Article : Google Scholar | |
|
Madisch A, Bethke B, Stolte M and Miehlke S: Is there an association of microscopic colitis and irritable bowel syndrome - a subgroup analysis of placebo-controlled trials. World J Gastroenterol. 11:64092005.PubMed/NCBI | |
|
Rahman MA, Raihan AS, Ahamed DS, et al: Symptomatic overlap in patients with diarrhea predominant irritable bowel syndrome and microscopic colitis in a sub group of Bangladeshi population. Bangladesh Med Res Counc Bull. 38:33–38. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Arevalo F, Aragon V, Montes P, Guzman E and Monge E: Increase of intraepithelial lymphocytes in patients with irritable bowel syndrome. Rev Gastroenterol Peru. 31:315–318. 2011.(In Spanish). | |
|
El-Salhy M, Lomholt-Beck B and Hausken T: Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 45:1435–1439. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dewar DH, Donnelly SC, McLaughlin SD, Johnson MW, Ellis HJ and Ciclitira PJ: Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol. 18:1348–1356. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wolber R, Owen D and Freeman H: Colonic lymphocytosis in patients with celiac sprue. Hum Pathol. 21:1092–1096. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Green PH, Yang J, Cheng J, Lee AR, Harper JW and Bhagat G: An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 7:1210–1216. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fraser AG, Warren BF, Chandrapala R and Jewell DP: Microscopic colitis: a clinical and pathological review. Scand J Gastroenterol. 37:1241–1245. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Abdulkarim AS and Murray JA: Celiac disease. Curr Treat Options Gastroenterol. 5:27–38. 2002. View Article : Google Scholar | |
|
Ciclitira PJ, King AL and Fraser JS: AGA technical review on Celiac Sprue. American Gastroenterological Association Gastroenterology. 120:1526–1540. 2001.PubMed/NCBI | |
|
Perk G, Ackerman Z, Cohen P and Eliakim R: Lymphocytic colitis: a clue to an infectious trigger. Scand J Gastroenterol. 34:110–112. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
LaSala PR, Chodosh AB, Vecchio JA, Schned LM and Blaszyk H: Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol. 39:891–893. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Erim T, Alazmi WM, O'Loughlin CJ and Barkin JS: Collagenous colitis associated with Clostridium difficile: a cause effect? Dig Dis Sci. 48:1374–1375. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bohr J, Nordfelth R, Jarnerot G and Tysk C: Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol. 37:711–714. 2002. View Article : Google Scholar | |
|
Makinen M, Niemela S, Lehtola J and Karttunen TJ: Collagenous colitis and Yersinia enterocolitica infection. Dig Dis Sci. 43:1341–1346. 1998. View Article : Google Scholar | |
|
Spiller RC, Jenkins D, Thornley JP, et al: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tamboli CP, Good MR, Reynolds EM, Sharma P and Mitros FA: Anti-Yersinia antibodies are not associated with microscopic colitis in an American case-control study. Scand J Gastroenterol. 46:1442–1448. 2011. | |
|
Madisch A, Hellmig S, Schreiber S, Bethke B, Stolte M and Miehlke S: Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis. Inflamm Bowel Dis. 17:2295–2298. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Spiller R and Garsed K: Postinfectious irritable bowel syndrome. Gastroenterology. 136:1979–1988. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dunlop SP, Jenkins D, Neal KR and Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 125:1651–1659. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol. 18:6070–6075. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Park JH, Rhee PL, Kim G, et al: Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 18:539–546. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim HS, Lim JH, Park H and Lee SI: Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection - an observation in a small case control study. Yonsei Med J. 51:45–51. 2010.PubMed/NCBI | |
|
Beaugerie L and Pardi DS: Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 22:277–284. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandez-Banares F, Esteve M, Espinos JC, et al: Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 102:324–330. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bjarnason I, Hayllar J, MacPherson AJ and Russell AS: Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 104:1832–1847. 1993.PubMed/NCBI | |
|
Leung WK, Bjarnason I, Wong VW, Sung JJ and Chan FK: Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet. 369:6142007. View Article : Google Scholar : PubMed/NCBI | |
|
Takeuchi K, Smale S, Premchand P, et al: Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 4:196–202. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tysk C, Bohr J, Nyhlin N, Wickbom A and Eriksson S: Diagnosis and management of microscopic colitis. World J Gastroenterol. 14:7280–7288. 2008. View Article : Google Scholar | |
|
Giardiello FM, Lazenby AJ, Yardley JH, et al: Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig Dis Sci. 37:496–499. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Ilonen J and Karttunen RA: Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol. 20:276–282. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Bloigu RS and Karttunen RA: Cytokine gene polymorphism in microscopic colitis association with the IL-6–174 GG genotype. Eur J Gastroenterol Hepatol. 23:607–613. 2011.PubMed/NCBI | |
|
Lundberg JO, Herulf M, Olesen M, et al: Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest. 27:869–871. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Olesen M, Middelveld R, Bohr J, et al: Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand J Gastroenterol. 38:66–72. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kolios G, Rooney N, Murphy CT, Robertson DA and Westwick J: Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 43:56–63. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mourad FH, Turvill JL and Farthing MJ: Role of nitric oxide in intestinal water and electrolyte transport. Gut. 44:143–147. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Kuwahara A, Kuramoto H and Kadowaki M: 5-HT activates nitric oxide-generating neurons to stimulate chloride secretion in guinea pig distal colon. Am J Physiol. 275:G829–G834. 1998.PubMed/NCBI | |
|
Gershon MD: Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol. 3:600–607. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kellum JM, Albuquerque FC, Stoner MC and Harris RP: Stroking human jejunal mucosa induces 5-HT release and Cl- secretion via afferent neurons and 5-HT4 receptors. Am J Physiol. 277:G515–G520. 1999.PubMed/NCBI | |
|
Walsh JH: Gastrointestinal hormones. Physiology of the Gastrointestinal Tract. Johnson LR, Alpers DH, Christensen J, Jacobson ED and Walsh JH: Raven Press; New York: pp. 1–128. 1994 | |
|
Goumain M, Voisin T, Lorinet AM, et al: The peptide YY- preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol. 60:124–134. 2001. | |
|
Souli A, Chariot J, Voisin T, et al: Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides. 18:551–557. 1997. View Article : Google Scholar | |
|
Whang EE, Hines OJ, Reeve JR Jr, et al: Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis Sci. 42:1121–1127. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Moriya R, Shirakura T, Hirose H, Kanno T, Suzuki J and Kanatani A: NPY Y2 receptor agonist PYY(3–36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Peptides. 31:671–675. 2010. | |
|
Khan WI and Ghia JE: Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 161:19–27. 2010.PubMed/NCBI | |
|
Yang GB and Lackner AA: Proximity between 5-HT secreting enteroendocrine cells and lymphocytes in the gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5-HT in mucosal immunity. J Neuroimmunol. 146:46–49. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Briejer MR, Akkermans LM, Meulemans AL, Lefebvre RA and Schuurkes JA: Nitric oxide is involved in 5-HT-induced relaxations of the guinea-pig colon ascendens in vitro. Br J Pharmacol. 107:756–761. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Stoner MC, Scherr AM, Lee JA, Wolfe LG and Kellum JM: Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon. Surgery. 128:240–245. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Stoner MC and Kellum JM: Both serotonin and a nitric-oxide donor cause chloride secretion in rat colonocytes by stimulating cGMP. Surgery. 130:236–241. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kadowaki M, Gershon MD and Kuwahara A: Is nitric oxide involved in 5-HT-induced fluid secretion in the gut? Behav Brain Res. 73:293–296. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Protic M, Jojic N, Bojic D, et al: Mechanism of diarrhea in microscopic colitis. World J Gastroenterol. 11:5535–5539. 2005.PubMed/NCBI | |
|
Stroehlein JR: Microscopic colitis. Curr Treat Options Gastroenterol. 10:231–236. 2007. View Article : Google Scholar | |
|
Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A and Fernandez-Banares F: Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 5:612–618. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chande N: Microscopic colitis: an approach to treatment. Can J Gastroenterol. 22:686–688. 2008.PubMed/NCBI | |
|
Fernandez-Banares F, Salas A, Esteve M, Espinos J, Forne M and Viver JM: Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol. 98:340–347. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Calabrese C, Fabbri A, Areni A, Zahlane D, Scialpi C and Di Febo G: Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol. 22:809–814. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Miehlke S, Madisch A, Karimi D, et al: Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 136:2092–2100. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Pardi DS, Loftus EV Jr, Tremaine WJ and Sandborn WJ: Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 120:1483–1484. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Fine KD and Lee EL: Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology. 114:29–36. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Vennamaneni SR and Bonner GF: Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol. 96:2798–2799. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Varghese L, Galandiuk S, Tremaine WJ and Burgart LJ: Lymphocytic colitis treated with proctocolectomy and ileal J-pouch-anal anastomosis: report of a case. Dis Colon Rectum. 45:123–126. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ostgaard H, Hausken T, Gundersen D and El-Salhy M: Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep. 5:1382–1390. 2012.PubMed/NCBI | |
|
El-Salhy M, Ostgaard H, Gundersen D, Hatlebakk JG and Hausken T: The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int J Mol Med. 29:723–731. 2012.PubMed/NCBI | |
|
El-Salhy M, Lillebø E, Reinemo A, Salmelid L and Hausken T: Effects of a health program comprising reassurance, diet management, probiotics administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterology Insights. 2:21–26. 2010. View Article : Google Scholar |
